semaglutide site reaction injection reactions: what to do TrimRX | GLP-1 Injection Site

38 A key benefit of GLP-1R agonists is the glucose-dependent insulinotropic function, with reduction in blood glucose only in hyperglycemia, eliminating the hypoglycemia risk of many other antidiabetic drugs

Like this

Maybe a reduced appetite that is more intense than usual for a day or two

Leading companies such as Novo Nordisk, Eli Lilly, and Sanofi continue to drive innovation, introducing next-generation peptides with improved efficacy, extended half-life, and enhanced patient adherence

Communication could have been better but, the product works

Tirzepatide side effects (Phase 3 data) Nausea: 24-33% of participants (dose-dependent) Diarrhea: 18-23% Vomiting: 8-13% Constipation: 11-17% Discontinuation due to adverse events: 4.3-7.1% Serious adverse events: similar to placebo The difference in discontinuation rates is striking